Potomac, MD, United States of America

Ryuji Ueno

Average Co-Inventor Count = 1.6

ph-index = 22

Forward Citations = 1,507(Granted Patents)

Forward Citations (Not Self Cited) = 987(Sep 21, 2024)

DiyaCoin DiyaCoin 4.89 

Inventors with similar research interests:


Location History:

  • Kyoto, JP (1989 - 1995)
  • Hyogo-ken, JP (1996 - 1997)
  • Hyogo, JP (1989 - 2001)
  • Nishinomiya, JP (1990 - 2002)
  • Montgomery, JP (2002)
  • Montgomery, MD (US) (2001 - 2016)
  • Potomac, MD (US) (2002 - 2016)
  • Saint Michaels, MD (US) (2016)
  • St Michaels, MD (US) (2017)
  • Easton, MD (US) (2016 - 2022)


Years Active: 1989-2025

where 'Filed Patents' based on already Granted Patents

151 patents (USPTO):
17 patents (CIPO):

Title: Ryuji Ueno - Innovator Extraordinaire

Introduction:

Ryuji Ueno, a prominent inventor and innovator based in Potomac, MD, has made significant contributions to the fields of biotechnology and pharmaceuticals. With an impressive portfolio of 149 patents to his name, Ueno's innovative work has revolutionized the medical landscape. This article aims to delve into his latest patents, highlight his illustrious career, and explore his collaborations with fellow professionals.

Latest Patents:

Ueno's recent patents demonstrate his multidisciplinary expertise and his commitment to advancing medical research. One notable invention is the Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope protein. This invention provides a revolutionary particle with a polypeptide and at least one antigen, paving the way for advanced vaccine development. Additionally, Ueno has patented a pharmaceutical combination of opioid and prostaglandin compounds, offering a novel treatment method for various conditions requiring opioid use.

Career Highlights:

Throughout his career, Ueno has held significant positions in renowned companies dedicated to medical advancements. He has been associated with Sucampo Ag, a pharmaceutical company specializing in the development of innovative medicines. Ueno's expertise and leadership have undoubtedly contributed to the success of Sucampo Ag.

Collaborations:

Collaboration has been a key aspect of Ueno's journey. He has worked alongside esteemed professionals, such as Ryuzo Ueno and Tomio Oda. Their collaborative efforts have resulted in groundbreaking discoveries and remarkable research outcomes. Ueno's ability to foster strong alliances showcases his commitment to excellence and his recognition of the power of teamwork in driving innovation.

Conclusion:

Ryuji Ueno's contributions to the realms of biotechnology and pharmaceuticals have left an indelible mark. With an extensive patent portfolio and a commitment to advancing medical research, Ueno continues to inspire future inventors and innovators. His ingenuity, combined with his dedication to collaborative partnerships, has propelled him to the forefront of scientific advancement. As an exemplary figure in the field, Ueno serves as a beacon, illuminating the path for aspiring inventors and revolutionizing the realms of healthcare and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…